| P50 | author | Alix Lacoste | Q62066722 |
| | Rita Sattler | Q67207325 |
| | Robert Bowser | Q89843147 |
| P2093 | author name string | Scott Spangler | |
| | Nadine Bakkar | |
| | Ileana Lorenzini | |
| | Elenee Argentinis | |
| | Kyle Sponaugle | |
| | Philip Ferrante | |
| | Tina Kovalik | |
| P2860 | cites work | Interaction between the shuttling mRNA export factor Gle1 and the nucleoporin hCG1: a conserved mechanism in the export of Hsp70 mRNA. | Q24530613 |
| | Higher order arrangement of the eukaryotic nuclear bodies | Q24536097 |
| | Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis | Q24605104 |
| | Distinct structural features of caprin-1 mediate its interaction with G3BP-1 and its induction of phosphorylation of eukaryotic translation initiation factor 2alpha, entry to cytoplasmic stress granules, and selective interaction with a subset of mR | Q24681390 |
| | IBM Watson: How Cognitive Computing Can Be Applied to Big Data Challenges in Life Sciences Research | Q26748818 |
| | State of play in amyotrophic lateral sclerosis genetics | Q26864816 |
| | The Spinal Muscular Atrophy Disease Protein SMN Is Linked to the Golgi Network | Q27329644 |
| | ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1 | Q28115018 |
| | Proto-oncoprotein TLS/FUS is associated to the nuclear matrix and complexed with splicing factors PTB, SRm160, and SR proteins | Q28208722 |
| | Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons? | Q28214361 |
| | Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis | Q28237200 |
| | Familial Amyotrophic Lateral Sclerosis | Q54158931 |
| | SMN1 gene, but not SMN2, is a risk factor for sporadic ALS | Q58152626 |
| | A census of human RNA-binding proteins | Q58283908 |
| | p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS | Q58477808 |
| | Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs | Q85925919 |
| | Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease | Q28244731 |
| | NEK1 variants confer susceptibility to amyotrophic lateral sclerosis | Q28277378 |
| | C9orf72 nucleotide repeat structures initiate molecular cascades of disease. | Q33715387 |
| | ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. | Q34068067 |
| | Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum | Q34075618 |
| | Fragile Mental Retardation Protein Interacts with the RNA-Binding Protein Caprin1 in Neuronal RiboNucleoProtein Complexes | Q34318418 |
| | Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis | Q35063153 |
| | Transcript and protein expression decoupling reveals RNA binding proteins and miRNAs as potential modulators of human aging. | Q35222558 |
| | Unraveling the cerebellar cortex: cytology and cellular physiology of large-sized interneurons in the granular layer | Q35667795 |
| | Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy. | Q35746397 |
| | The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. | Q36319626 |
| | Hyperactive somatostatin interneurons contribute to excitotoxicity in neurodegenerative disorders. | Q36739537 |
| | Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. | Q36795394 |
| | Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways | Q37099358 |
| | Genetics of amyotrophic lateral sclerosis: an update. | Q37153922 |
| | Variants in HNRNPH2 on the X Chromosome Are Associated with a Neurodevelopmental Disorder in Females | Q37231343 |
| | Delivery of AAV-IGF-1 to the CNS extends survival in ALS mice through modification of aberrant glial cell activity | Q37331730 |
| | Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxic | Q37503127 |
| | The genetics and neuropathology of amyotrophic lateral sclerosis | Q38035744 |
| | Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene | Q38952327 |
| | Decoding ALS: from genes to mechanism. | Q39004348 |
| | Disease Mechanisms of C9ORF72 Repeat Expansions | Q39107075 |
| | The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. | Q39396328 |
| | Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. | Q39761567 |
| | Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. | Q40368684 |
| | Subnuclear targeting of the RNA-binding motif protein RBM6 to splicing speckles and nascent transcripts | Q42818077 |
| | Distribution of GABAAReceptor mRNA in the Motor Cortex of ALS Patients | Q44629514 |
| | hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations | Q44742682 |
| | Cortical selective vulnerability in motor neuron disease: a morphometric study. | Q44886501 |
| | Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice. | Q45923964 |
| | TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics | Q47939995 |
| | Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. | Q48183466 |
| | Detection of a novel frameshift mutation and regions with homozygosis within ARHGEF28 gene in familial amyotrophic lateral sclerosis | Q48226607 |
| | GABA(A)-receptor mRNA expression in the prefrontal and temporal cortex of ALS patients | Q48408651 |
| | Calcium-binding proteins in primate cerebellum | Q48474190 |
| | Immunohistochemical study on the distribution of phosphorylated extracellular signal-regulated kinase (ERK) in the central nervous system of SOD1G93A transgenic mice | Q48833773 |
| | Analysis of hnRNPA1, A2/B1, and A3 genes in patients with amyotrophic lateral sclerosis. | Q50857769 |
| | Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions | Q52146520 |
| | MTHFSD and DDX58 are novel RNA-binding proteins abnormally regulated in amyotrophic lateral sclerosis | Q52147259 |
| | RBMS3 is a tumor suppressor gene that acts as a favorable prognostic marker in lung squamous cell carcinoma | Q53644101 |
| P433 | issue | 2 | |
| P921 | main subject | artificial intelligence | Q11660 |
| | IBM | Q37156 |
| | amyotrophic lateral sclerosis | Q206901 |
| | neurodegeneration | Q1755122 |
| P304 | page(s) | 227-247 | |
| P577 | publication date | 2017-11-13 | |
| P1433 | published in | Acta Neuropathologica | Q343168 |
| P1476 | title | Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis | |
| P478 | volume | 135 | |